Systemic Autoimmune, Rheumatic Diseases and Coinciding Psoriasis: Data from a Large Single-Centre Registry and Review of the Literature

Table 4

Patient characteristics with SLE only.

The age of SLE onset	Comorbidity	Immunoserology	Actual clinical status	Therapy	Corticosteroids (mg PED)	SLICC
27 yrs	—	ANA, a-SSA, a-SSB, a-U1RNP, hypocomplementaemia	Remission	Azathioprine, low-dose corticosteroid	13.75	0
54 yrs	Gout, diabetes mellitus, COPD, ischemic heart disease	ANA, a-dsDNA, a-chromatin	Remission	Low-dose corticosteroid	12.5	1
45 yrs	—	ANA, a -Sm, a-SSA, a-U1RNP, aCL IgM	Remission	—	20	2
24 yrs	Raynaud’s syndrome, Sjögren’s syndrome, Hashimoto-thyroiditis, seronegative rheumatoid arthritis (erosive polyarthritis), idiopathic thrombocytopenic purpura	ANA, a-ENA, a-SSA, a-dsDNA, a-Sm, a-TPO	Remission	—	10	0
33 yrs	Sjögren’s syndrome	ANA, a-dsDNA, a-SSA, a-SSB, aCL IgM	Remission	—	8.7	0
58 yrs	Sjögren’s syndrome,	ANA, a-dsDNA, a-SSA, a-SSB,	Remission	—	8.75	0
	type 2 diabetes mellitus
57 yrs	Rheumatoid arthritis, sacroiliitis	ANA, a-ACPA, a-dsDNA, a-Sm, a-U1RNP	Remission	—	7.5	0
29 yrs	Rheumatoid arthritis, asthma bronchial, aseptic femur-head necrosis, cataract, glaucoma	ANA, a-ACPA, a-dsDNA	Remission	—	10	2

SLE: systemic lupus erythematosus, COPD: chronic obstructive pulmonary disease, ILD: interstitial lung disease, ANA: anti-nuclear antibody, a-SSA: anti-Sjögren’s syndrome A antibody, a-SSB: anti-Sjögren’s syndrome B antibody, a-chromatin: anti-chromatin antibody, anti-RNP: anti-ribonucleoprotein antibody, a-dsDNA: anti-double stranded deoxyribonucleic acid antibody, anti-Sm: anti-Smith antibody, aCL IgM: anti-cardiolipin antibody immunoglobulin M, a-U1RNP: anti-U1 ribonucleoprotein antibody, a-TPO: anti-thyreoid peroxidase antibody, MMF: mycophenolate mofetil, PED: prednisolone equivalent dose, and SLICC: systemic lupus international collaborating clinics.